Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. TILS.L Share Price
  4. TILS.L Share Regulatory News
  5. Board Changes

Pin to quick picksTILS.L Regulatory News (TILS)

TILS.L Information
  • There is currently no data for TILS

Board Changes

9 Jul 2008 16:16

RNS Number : 7207Y
ReGen Therapeutics PLC
09 July 2008
 

 

 

9th July 2008

ReGen Therapeutics Plc <AIM:RGT>

Board Changes

ReGen Therapeutics Plc ('ReGen' or 'the Company') announces that Keith Corbin has resigned his position as deputy chairman and non-executive director to the Company with immediate effect.

Mr Corbin has resigned because his business commitments have expanded, particularly outside of Europe, making it difficult for him to properly fulfil his role at ReGen.

The Board thanks Keith for his contribution to ReGen and wishes him every success in developing his business.

 

For further information:

Percy LomaxReGen Therapeutics PlcTel No 020 7153 4920

Roland Cornish/Felicity GeidtBeaumont CornishTel No 020 7628 3396

David Scott/Nick BealerAlexander DavidTel No 020 7448 9800

 

Adrian Duffield/Jon DaviesCollege Hill AssociatesTel No 020 7457 2020

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUKAVRWRRBRAR
12345678910
Date   Source Headline
28th May 20197:00 amRNS9th Annual LD Micro Invitational
7th May 20197:00 amRNSNotice of AGM
2nd May 20197:00 amRNSDirector/PDMR Shareholding
1st May 20197:00 amRNSUpdate on IND Application
25th Apr 20195:00 pmRNSDirector/PDMR Shareholding
24th Apr 201912:55 pmRNSReissue: Interim Clinical Data
24th Apr 20197:00 amRNSInterim Clinical Data
15th Apr 20195:45 pmRNSHolding(s) in Company
15th Apr 20195:45 pmRNSHolding(s) in Company
15th Apr 20195:45 pmRNSHolding(s) in Company
4th Apr 20197:00 amRNSFinal Results
20th Mar 20197:00 amRNSIND Application Submitted for NASH Oral Treatment
7th Feb 20197:00 amRNSDirectorate Change
11th Dec 20187:00 amRNSExercise of Warrants & Issue of Equity
3rd Dec 20187:00 amRNSMilciclib HCC Phase IIa Trial Enrollment Completed
28th Nov 20187:00 amRNSForalumab: Phase 1 Trial with Nasal Administration
27th Nov 20187:00 amRNSHolding(s) in Company
26th Nov 20187:00 amRNSStatement re: ADSs
23rd Nov 20185:00 pmRNSClosing of Offering and Total Voting Rights
20th Nov 20187:30 amRNSDiscounted exercise prices of outstanding warrants
20th Nov 20187:00 amRNSOffer Pricing, Nasdaq Listing & Loan Conversion
18th Oct 20187:15 amRNSAmended Registration Statement filed with the SEC
16th Oct 20187:00 amRNSMilciclib synergistic activity presented at AASLD
25th Sep 20187:00 amRNSTiziana announces Offering & Application to Nasdaq
24th Sep 20187:03 amRNSInterim Results for Six Months Ended 30 June 2018
24th Sep 20187:00 amRNSU.S. FDA Approval IND Nasal Foralumab Phase 1
13th Sep 20181:05 pmRNSPDMR Dealing
12th Sep 20187:00 amRNSPDMR dealings
11th Sep 20187:00 amRNSPDMR Dealing
24th Aug 20187:00 amRNSPDMR Dealing
21st Aug 20187:00 amRNSPDMR dealings
20th Aug 20187:00 amRNSPDMR Dealing
17th Aug 20187:00 amRNSPDMR Dealing
16th Aug 20189:00 amRNSFiling of Investigational New Drug application
27th Jul 20187:00 amRNSUS Registration Statement for Proposed Offering
25th Jun 201810:49 amRNSResult of AGM
7th Jun 20187:01 amRNSAppointment of Broker
7th Jun 20187:00 amRNSFinal Results
1st Jun 20187:00 amRNSNotice of AGM
23rd May 20184:40 pmRNSSecond Price Monitoring Extn
23rd May 20184:35 pmRNSPrice Monitoring Extension
16th May 20187:00 amRNSMilciclib Phase 2a Trial - Tolerability Update
1st May 20183:00 pmRNSGrant of Options - Director Dealing
27th Apr 20187:00 amRNSIssue of Equity
19th Apr 20187:00 amRNSSubscription
16th Apr 20187:25 amRNSLicense Agreement
9th Apr 20188:25 amRNSPresentation at ASCO 3 June 2018
5th Apr 20187:00 amRNSAppointment of Broker
4th Apr 20187:00 amRNSAppointment of Director
5th Mar 20187:00 amRNSPlacing to raise £600,000 and issue of equity
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
PSRE
Ivz Rafi Eur
LSE
0.50%
QED
Quadrise
LSE
0.00%
BERI
Blackrock Engy
LSE
-2.01%
EAT
European Assets Trust
LSE
0.00%
I500
Is Sp500 Swp
LSE
-0.46%
Trending
AVCT
Avacta Group
LSE
2.14%
ALRT
Defence Holdings
LSE
23.81%
PREM
Premier African Minerals
LSE
-2.38%
GST
GSTechnologies
LSE
8.11%
LLOY
Lloyds
LSE
-0.40%